Integral Molecular In response to the COVID-19 pandemic, AboundBio developed potent neutralizing monoclonal antibodies (MAbs) against SARS-CoV-2.
Integral Molecular News
MPA – How the Membrane Proteome Array Enabled Rapid Progression of a Neutralizing SARS-CoV-2 MAb
8/29 – 9/1 | Boston, MA
17th Vaccine Congress
9/24 – 9/27 | Glasgow, Scotland
Discovery on Target
9/25 – 9/28 | Boston, MA